Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 1, 2022, Cytek Biosciences, Inc. (the "Company") held its 2022 annual meeting of stockholders (the "Annual Meeting"). Of the 134,242,304 shares of the Company's common stock outstanding as of the close of business on the record date of April 4, 2022, 115,966,354 shares were represented at the Annual Meeting, either present at the virtual meeting or by proxy, constituting approximately 86% of the outstanding shares of common stock entitled to vote. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below:



1.  Election of Class I Directors. Each of the following nominees was elected to
    serve as a Class I director, to hold office until the Company's 2025 annual
    meeting of stockholders or until his or her successor has been duly elected
    and qualified or his or her earlier death, resignation or removal:



Nominee        Votes For    Votes Withheld   Broker Non-Votes
Deborah Neff   88,739,812      609,979          26,616,563
Don Hardison   88,652,419      697,372          26,616,563

2. Ratification of the Selection of Independent Registered Public Accounting

Firm. The selection of Deloitte & Touche LLP as the Company's independent

registered public accounting firm for the fiscal year ending December 31,

2022 was ratified based on the following results of voting:





 Votes For    Votes Against   Abstentions   Broker Non-Votes
115,377,037       5,450         583,867            -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses